Use of BPRS - A percent change scores to identify significant clinical improvement: Accuracy of treatment response classification in acute psychiatric inpatients

Psychiatry Research

Volumn 89, Issue 3, 1999, Pages 259-268

  Lachar, David ^a   Bailley, Steven E ^a   Rhoades, Howard M ^a   Varner, Roy V ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Brief Psychiatric Rating Scale; Classification; Drugs; Instrumentation; Program evaluation; Psychometrics; Psychotropic

Indexed keywords

ADULT; ARTICLE; CLASSIFICATION; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL PATIENT; METHODOLOGY; PRIORITY JOURNAL; PSYCHOMETRY; RATING SCALE; SYMPTOM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HOSPITALS, PSYCHIATRIC; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOTIC DISORDERS; SUBSTANCE-RELATED DISORDERS; TEXAS;

EID: 0033373959     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(99)00114-6     Document Type: Article

References (36)

1. Arvanitis L.A, Miller B.G. Multiple fixed doses of 'Seroquel' (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Biological Psychiatry. 42:1997;233-246.
2. Berman W.H., Rosen C.S., Hurt S.W., Kolarz C.M. Toto, we're not in Kansas anymore: measuring and using outcomes in behavioral health care. Clinical Psychology: Science and Practice. 5:1998;115-133.
3. Buckley P.F. New dimensions in pharmacologic treatment of schizophrenia and related psychoses. Journal of Clinical Pharmacology. 37:1997;363-378.
4. Clothier J.L., Pazzaglia P.J., Freeman T.W., Davidlesen M., Swann A.C. Plasma level response characteristics of valproate in the treatment of manic syndrome. Annals of Clinical Psychiatry. 3:1991;321-324.
5. Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed. 1988;Lawrence Erlbaum, Hillsdale, NJ.
6. Eisele R., Gex-Fabry M., Balant-Gorgia A.E., Balant L., Garrone G. Rationale for BPRS use in routine clinical practice: quantitative assessment of psychopathology, consistent with clinical sense. European Psychiatry. 6:1991;261-268.
7. Essock S.M., Hargreaves W.A., Covell N.H., Goethe J. Antipsychotics in research and clinical settings. Psychopharmacology Bulletin. 32:1996;683-697.
8. Faustman W.O., Overall J.E. Brief Psychiatric Rating Scale. Maruish M. The Use of Psychological Testing for Treatment Planning and Outcome Assessment, 2nd ed. 1999;791-830 Lawrence Erlbaum Associates, Hillsdale, NJ.
9. Fombonne E., Peron-Magnan P., Fuhrer R., Simon P. Comparative study of four evaluation criteria in a clinical trial with schizophrenic patients. Neuropsychobiology. 16:1986;186-192.
10. Friedman L., Knutson L., Shurell M., Meltzer H.Y. Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia. Biological Psychiatry. 29:1991;865-877.
11. Gabbard G.O., Coyne L., Kennedy L.L., Beasley C., Deering C.D., Schroder P., Larson J., Cerney M.S. Interrater reliability in the use of the Brief Psychiatric Rating Scale. Bulletin of the Menninger Clinic. 51:1987;519-531.
12. Hamilton S.H., Revicki D.A., Genduso L.A., Beasley C.M. Olanzapine versus placebo and haloperidol: quality of life and efficacy results of the North American double-blind trial. Neuropsychopharmacology. 18:1998;41-49.
13. Hanley J.A., McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 148:1983;839-843.
14. Hedlund J.L., Vieweg B.W. The Brief Psychiatric Rating Scale (BPRS): a comprehensive review. Journal of Operational Psychiatry. 11:1980;48-65.
15. Imbornoni S., Donenwirth K., Orr B., Hagesfeld T., Gintoli G., Buckley P. Objective measurement of psychiatric symptoms: a quality improvement process for inpatient care. Joint Commission Journal on Quality Improvement. 23:1997;183-195.
16. Kane J., Honigfeld G., Singer J., Meltzer H. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Archives of General Psychiatry. 45:1988;789-796.
17. Kraemer H.C. Evaluating Medical Tests: Objective and Quantitative Guidelines. 1992;Sage Publications, Inc, Newbury Park, CA.
18. Lieberman P.B., Wiitala S.A., Elliott B., McCormick S., Goyette S.B. Decreasing length of stay: are there effects on outcomes of psychiatric hospitalizations? American Journal of Psychiatry. 155:1998;905-909.
19. Lukoff D., Neuchterlein K.H., Ventura J. Manual for Expanded Brief Psychiatric Rating Scale (BPRS). Schizophrenia Bulletin. 12:1986;594-602.
20. Lyons J.S., Howard K.I., O'Mahoney M.T., Lish J.D. The Measurement and Management of Clinical Outcomes in Mental Health. 1997;John Wiley, New York.
21. Manchanda R., Hirsch S.R., Barnes T.R.E. Criteria for evaluating improvement in schizophrenia in psychopharmacological research with special reference to gamma endorphin fragments. British Journal of Psychiatry. 153:1988;354-358.
22. Morlan K.K., Tan S.-Y. Comparison of the Brief Psychiatric Rating Scale and the Brief Symptom Inventory. Journal of Clinical Psychology. 54:1998;885-894.
23. Mulsant B.H., Mazumdar S., Pollock B.G., Sweet R.A., Rosen J., Lo K. Methodological issues in characterizing treatment response in demented patients with behavioral disturbances. International Journal of Geriatric Psychiatry. 12:1997;537-547.
24. Nicholson I.R., Chapman J.E., Neufeld R.W.J. Variability in BPRS definitions of positive and negative symptoms. Schizophrenia Research. 17:1995;177-185.
25. Overall J.E. The Brief Psychiatric Rating Scale in psychopharmacology research. Pichot P. Psychological Measurements in Psychopharmacology: Modern Problems in Pharmacopsychiatry. 1974;67-78 Karger, Basel.
26. Overall J.E., Gorham D.R. The Brief Psychiatric Rating Scale. Psychological Reports. 10:1962;799-812.
27. Overall J.E., Gorham D.R. The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacology Bulletin. 24:1988;97-99.
28. Sajatovic M., Meltzer H.Y. The effect of short-term electroconvulsive treatment plus neuroleptics in treatment-resistant schizophrenia and schizoaffective disorder. Convulsive Therapy. 9:1993;167-175.
29. Schulz S.C., Buckley P.F. Treatment-resistant schizophrenia. Hirsch S.R., Weinberger D.R. Schizophrenia. 1995;468-484 Blackwell Science Ltd, Oxford.
30. Schulz S.C., Tamminga C.A. Schizophrenia: Scientific Progress. 1989;Oxford University Press, New York.
31. Smith R.C., Chua J.W., Lipetsker B., Bhattacharyya A. Efficacy of risperidone in reducing positive and negative symptoms in medication-refractory schizophrenia: an open prospective study. Journal of Clinical Psychiatry. 57:1996;460-466.
32. Tarell J.D., Schulz S.C. Nursing assessment using the BPRS: a structured interview. Psychopharmacology Bulletin. 24:1988;105-111.
33. Thompson P.A., Buckley P.F., Meltzer H.Y. The Brief Psychiatric Rating Scale: effect of scaling system on clinical response assessment. Journal of Clinical Psychopharmacology. 14:1994;344-346.
34. Ventura J., Green M.F., Shaner A., Liberman R.P. Training and quality assurance with the Brief Psychiatric Rating Scale: 'the drift busters'. International Journal of Methods in Psychiatric Research. 3:1993;221-244.
35. Volavka J., Cooper T.B., Czobor P., Meisner M. Plasma haloperidol levels and clinical effects in schizophrenia and schizoaffective disorder. Archives of General Psychiatry. 52:1995;837-845.
36. Woerner M.G., Mannuzza S., Kane J.M. Anchoring the BPRS: an aid to improved reliability. Psychopharmacology Bulletin. 24:1988;112-117.